Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Marianne O. Stefanini"'
Supplementary Methods, Glossary, Figure Legends 1-3 from Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215999e4b51339ed48832155ce894cd7
https://doi.org/10.1158/0008-5472.22386938.v1
https://doi.org/10.1158/0008-5472.22386938.v1
Supplementary Figure 1 from Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a0bc333de9a4469a8fecefdae3dbf9a
https://doi.org/10.1158/0008-5472.22386947.v1
https://doi.org/10.1158/0008-5472.22386947.v1
Supplementary Figure 3 from Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266b1ce3687fdd6ac725bb67c109cca7
https://doi.org/10.1158/0008-5472.22386941
https://doi.org/10.1158/0008-5472.22386941
Supplementary Tables 2-5 from Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::964b2af9223c12838e5c67bba41c107f
https://doi.org/10.1158/0008-5472.22386932.v1
https://doi.org/10.1158/0008-5472.22386932.v1
Supplementary Table 1 from Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f11e8693b2e90274c66bb01d0002e61
https://doi.org/10.1158/0008-5472.22386935.v1
https://doi.org/10.1158/0008-5472.22386935.v1
Supplementary Figure 2 from Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98d10fa1a93154ecb4856ae218f27eb6
https://doi.org/10.1158/0008-5472.22386944
https://doi.org/10.1158/0008-5472.22386944
Publikováno v:
PLoS Computational Biology, Vol 5, Iss 12, p e1000622 (2009)
Vascular endothelial growth factor (VEGF) is a potent cytokine that binds to specific receptors on the endothelial cells lining blood vessels. The signaling cascade triggered eventually leads to the formation of new capillaries, a process called angi
Externí odkaz:
https://doaj.org/article/cade83ac73f145ee89877213d35f5ee4
Publikováno v:
PLoS ONE, Vol 4, Iss 4, p e5108 (2009)
Vascular endothelial growth factor (VEGF), through its activation of cell surface receptor tyrosine kinases including VEGFR1 and VEGFR2, is a vital regulator of stimulatory and inhibitory processes that keep angiogenesis--new capillary growth from ex
Externí odkaz:
https://doaj.org/article/535c8d177efe416582c1171d841a00ae
Autor:
Christopher D. Kontos, Florence T. H. Wu, Brian H. Annex, Marianne O. Stefanini, Feilim Mac Gabhann, Aleksander S. Popel
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 298:H2174-H2191
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis, the growth of new capillaries from existing microvasculature. In peripheral arterial disease (PAD), lower extremity muscle ischemia develops downstream of atherosclerotic o
Autor:
Christopher D. Kontos, Marianne O. Stefanini, Feilim Mac Gabhann, Florence T. H. Wu, Brian H. Annex, Aleksander S. Popel
Publikováno v:
Physiological Genomics. 38:29-41
Vascular endothelial growth factor (VEGF) signal transduction through the cell surface receptors VEGFR1 and VEGFR2 regulates angiogenesis—the growth of new capillaries from preexistent microvasculature. Soluble VEGF receptor-1 (sVEGFR1), a nonsigna